Diabetes Care · 2020 · 150 citations · 21 references
Life SciencesBiochemistryMicrobiologyMetabolomicsMicrobial MetabolismMicrobiome ResearchDiabetes MellitusMass Spectrometry-based MetabolomicsMetabolic SyndromeMetabolite ProfilingMicrobial MetabolomicsMicrobiome BiomarkersMetabolic Disease BiomarkersMetabolomic ChangesMicrobial Metabolite AlterationsMicrobial MetabolitesMicrobiome-associated MetabolitesMicrobiome-related MetabolomicsMicrobiota BiomarkersMicrobiota-derived Metabolites
OBJECTIVE: Recent studies have highlighted the significance of the microbiome in human health and disease. Changes in the metabolites produced by microbiota have been implicated in several diseases. Our objective was to identify microbiome metabolites that are associated with type 2 diabetes. RESEARCH DESIGN AND METHODS: ) having metabolomics data available. Metabolomics analysis was performed based on fasting plasma samples. On the basis of an oral glucose tolerance test, Matsuda ISI and disposition index values were calculated as markers of insulin sensitivity and insulin secretion. A total of 4,851 participants had a 7.4-year follow-up visit, and 522 participants developed type 2 diabetes. RESULTS: Creatine, 1-palmitoleoylglycerol (16:1), urate, 2-hydroxybutyrate/2-hydroxyisobutyrate, xanthine, xanthurenate, kynurenate, 3-(4-hydroxyphenyl)lactate, 1-oleoylglycerol (18:1), 1-myristoylglycerol (14:0), dimethylglycine, and 2-hydroxyhippurate (salicylurate) were significantly associated with an increased risk of type 2 diabetes. These metabolites were associated with decreased insulin secretion or insulin sensitivity or both. Among the metabolites that were associated with a decreased risk of type 2 diabetes, 1-linoleoylglycerophosphocholine (18:2) significantly reduced the risk of type 2 diabetes. CONCLUSIONS: Several novel and previously reported microbial metabolites related to the gut microbiota were associated with an increased risk of incident type 2 diabetes, and they were also associated with decreased insulin secretion and insulin sensitivity. Microbial metabolites are important biomarkers for the risk of type 2 diabetes.
21
High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes
Abbas Dehghan, Mandy van Hoek, Eric J.G. Sijbrands et al. · Diabetes Care · 2008 · 656 citations